Interest in probiotics continues to dominate the natural health products industry. While some evidence exists for the efficacy of probiotics in certain indications, many published studies lack the necessary methodological quality required to provide robust results. As the dietary supplement industry relies on ‘self-policing’ rather than premarket assessment, the bar for quality of scientific evidence is high.
This webinar will look at key aspects of good clinical practice, specific areas of methodologic concern and challenges with bacterial strains to ensure a robust clinical program.
In order to provide you with this free service, William Reed Business Media Ltd will share your information with companies that have content on this site ("third parties"). By filling in this web form you signify your consent to this and to receiving communications from us, in accordance with our Privacy & Cookies Policy, and from the third parties by post, phone, email or SMS.